Publications by authors named "E Barbara Helbig"

Claim this Profile
T
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.
Rainer Knoll, Elisa T Helbig, Kilian Dahm, Olufemi Bolaji, Frederik Hamm

Cell· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.
Joanna C Porter, Jamie Inshaw, Vincente Joel Solis, Emma Denneny, Rebecca Evans, Elisa Theresa Helbig

Elife· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, Veronica di Cristanziano, Kirsten A Eberhardt, Elisa T Helbig

JCI Insight· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial.
Florian Kurth, Elisa T Helbig, Lena J Lippert, Charlotte Thibeault, Gianluca Barbone

J Glob Antimicrob Resist· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteomic survival predictor for COVID-19 patients in intensive care.
Vadim Demichev, Pinkus Tober-Lau, Tatiana Nazarenko, Oliver Lemke, Simran Kaur Aulakh, Elisa T Helbig

PLOS Digit Health· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis